ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2015

Sarcoid Arthritis In World Trade Center Exposed New York City Firefighters Presenting As a Unique Clinical Subset

Konstantinos Loupasakis1, Jessica Berman2, Michelle S Glaser3,4, Nadia Jaber4, Rachel Zeig-Owens3,4, Mayris P Webber4,5, Michael D Weiden4,6, Anna Nolan4,7, Kerry J Kelly4 and David J Prezant4,8, 1Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, 2Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 3Medicine, Montefiore Medical Center, Bronx, NY, 4Bureau of Health Services Fire Department of New York, Brooklyn, NY, 5Medicine and Epideiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY, 6Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, 7Medicine, New York University School of Medicine, New York, NY, 8Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: arthritis management, environmental factors and sarcoidosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases II: Miscellaneous Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Sarcoidosis is a multisystem disease characterized by the formation of non-caseating granulomas with lungs being predominantly affected and the joints in up to 40%. Acute joint manifestations occur in 25-40% of patients and are often self-limited with only 1-4% of patients developing a more chronic arthritis, requiring more aggressive therapy, due to persistence or progression. We previously reported an increased incidence of sarcoidosis among Fire Department of the City of New York (FDNY) firefighters prior to 9/11/01 and an even higher incidence after World Trade Center (WTC) exposure. We now describe a series of FDNY firefighters who developed sarcoidosis following WTC rescue/recovery work with severe chronic polyarthritis as a significant component of their disease.

Methods: All FDNY WTC-exposed firefighters with polyarticular sarcoidosis are followed jointly by the WTC Health Program at FDNY and the Rheumatology Division at the Hospital for Special Surgery (HSS). Patient demographics, WTC-exposure information, smoking status, date of diagnosis, and pulmonary findings were obtained from FDNY’s WTC database. Joint findings (symptoms, duration, distribution of joints involved, treatments, and response) were obtained from HSS chart review.

Results: 11 male firefighters developed polyarticular arthritis after WTC-exposure; 2 had been diagnosed with sarcoidosis pre-9/11/01. All were never smokers and arrived at the WTC-site within 2 weeks after 9/11/01. Their median age was 37.7 years (IQR = 31.6-40.8), with a median of 6.9 years (IQR=4.4-13.2) of FDNY firefighting service pre-9/11/01. All had biopsy-proven pulmonary sarcoidosis, 9 by transbronchial or mediastinal lymph node biopsy, 1 by liver and bone biopsy and 1 by Kveim testing. All had normal pulmonary function tests at presentation. Duration from WTC-exposure to diagnosis of pulmonary sarcoidosis was 7.7 years (IQR=5.8-9.5). Polyarticular arthritis was part of the initial presentation in 9 patients who developed sarcoidosis post-9/11/01.  In 2 patients with pre-9/11/01 sarcoidosis, polyarticular arthritis occurred after WTC exposure, 5 and 10 years after their initial diagnosis.  Polyarthritis was symmetrical, involving large joints (n=1), small and large joints (n=10) and ankles (n=10). All had normal ESR and CRP; negative anti-CCP and Quantiferon or PPD. Only one had a positive RF and all but two had normal ACE levels. All required additional disease modifying agents for steroid sparing (stepwise progression from hydroxychloroquine->methotrexate->TNF-blocking agent). Adequate disease control was obtained with hydroxychloroquine (n=1); methotrexate (n=3); and anti-TNF agents (n=6).

Conclusion: Chronic polyarthritis appears to be an important manifestation of sarcoidosis in FDNY firefighters with sarcoidosis and WTC-exposure. Their arthritis appears to be chronic and most have not responded adequately to oral DMARDs, generally necessitating the addition of anti-TNF agents. Further studies are needed in order to determine the generalizability of these findings to other groups with varying levels of WTC-exposure or with non-WTC environmental/occupational exposures.


Disclosure:

K. Loupasakis,
None;

J. Berman,
None;

M. S. Glaser,
None;

N. Jaber,
None;

R. Zeig-Owens,
None;

M. P. Webber,
None;

M. D. Weiden,
None;

A. Nolan,
None;

K. J. Kelly,
None;

D. J. Prezant,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sarcoid-arthritis-in-world-trade-center-exposed-new-york-city-firefighters-presenting-as-a-unique-clinical-subset/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology